Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

71 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 20, 2025Feb 20 9:02 PMChad Robins
Proposed Sale
99,107$8.37$829.5K—

View →

Feb 19, 2025Feb 19 9:51 PMChad Robins
Proposed Sale
186,080$8.37$1.6M—

View →

Feb 18, 2025Feb 18 10:35 PMChad Robins
Proposed Sale
211,160$8.27$1.7M—

View →

Feb 14, 2025Feb 14 9:11 PMChad Robins
Proposed Sale
158,921$8.33$1.3M—

View →

Feb 13, 2025Feb 13 10:11 PMChad Robins
Proposed Sale
100,287$8.52$854.4K—

View →

Aug 22, 2024Aug 22 8:18 PMSTACY L TAYLOR
Proposed Sale
26,922$4.50$121.1K—

View →

← Previous

Page 10 of 10

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 4 of 4